Font Size:
a
A
A
Keyword [Her-2 positive]
Result: 1 - 20 | Page: 1 of 3
1.
Antitumor Activity Of Targeted Recombinant Human AIF On HER-2 Positive Carcinoma
2.
Role Of CEA,CA125,CA15-3 In Predicting Response Of Biochemotherapy In Her-2-positive Advanced Breast Cancer
3.
Cai A Mixture Of Addition And Subtraction Treatment Of Her-2 Positive Breast Cancer, The Efficacy Of Clinical Research
4.
The Effect Of Celecoxib On Proliferation And Apoptosis In Her-2/positive Human Gastric Cancer Cell NCI-N87
5.
Effects Of Trastuzumab Plus Chemoheraphy For The HER-2-positive Advanced Gastric Cancer Patients:a Meta‐analysis
6.
The Role Of TIP30and Egfr In HER-2-positive Advanced Breast Cancer And Its Clinical Significance
7.
The Pathological Characteristics Of Metastasis And Anti-Metastasis Effects Of BRACs On HER-2 Positive Cancer
8.
Black Rice Anthocyanins Inhibit HER-2-Positive Breast Cancer Epithelial–Mesenchymal Transition And Cell Metastasis Via FAK Signaling In Vitro
9.
Effects Of Notch Signaling Pathway Inhibitor On Her-2 Positive Cell Lines SK-BR3 With Stem Cells Properties
10.
Evaluation On Efficacy Of Trastuzumab In Her-2 Positive Breast Cancer Patients And Its Analysis Of Prognosis Influencing Factors
11.
Prognostic Analysis Of Targeted Therapy On T
1
Stage HER-2 Positive Breast Cancer
12.
Study Of Expression Of BRCA1,FANCF,CD44+CD24- In Triple Negative And Luminal B (Her-2 Positive) Breast Cancer
13.
The Clinical Observation Of Trastuzumab In First-line Treatment Of Her-2 Positive Metastatic Breast Cancer
14.
The Role And Molecular Mechanism Of Autophahgy In Delphinidin-induced Anticancer Effects For HER-2 Positive Breast Cancer
15.
Experimental Study Of Brain-Targeted Compound Nano Micelles In The Treatment Of Brain Metastases From HER-2-positive Breast Cancer
16.
Analysis Of The Clinical And Pathological Features Of The HER-2 Positive Breast Cancer
17.
The Predictive Value Of Tils For Trastuzumab In Her-2 Positive Breast Cancer
18.
Comparison Of Efficacy Of THL And TCH Regimen In Neoadjuvant Treatment Of Her-2 Positive Breast Cancer
19.
RBM38 Induces Tarstuzumab Sensitivity In HER-2 Positive Breast Cancer By Increasing The Expression Of HER-2
20.
Advance In Molecular Targeted Therapy For HER-2 Positive Breast Cancer
<<First
<Prev
Next>
Last>>
Jump to